Profilo
Stephan Rau is a Shareholder and Chair of the European Healthcare Practice at Greenberg Traurig. He focuses in advising on private equity/ M&A transactions, and regulatory in the healthcare and life sciences sectors. His clients include private equity and strategic investors, healthcare service providers, pharmaceutical companies, medical device manufacturers, and university institutions.
Due to his experience, Stephan Rau is recognized as a leading attorney in the legal directories. Since 2011, he has been continuously ranked by Chambers and Partners as a Tier 1 lawyer for healthcare in Germany and by Legal 500 Germany as an “Elite Leading Lawyer” for healthcare and life sciences. JUVE lists Stephan Rau as a frequently recommended lawyer for corporate, M&A and private equity, as well as a leading attorney in the healthcare sector. LMG Life Sciences Europe has repeatedly recognized him as a “Life Sciences Star” for his outstanding work in the industry.
Before joining Greenberg Traurig, Stephan Rau was a partner at McDermott and worked for international law firms in Moscow, Hamburg and Berlin.
Concentrations
- Private Equity
- Mergers & Acquisitions
- Healthcare
- Corporate law
- Health Regulation
Competenze
Riconoscimenti e Premi
- Handelsblatt/Best Lawyers, Germany: Biotechnology Law, Life Sciences Practice, Mergers and Acquisitions Law, Health Care Law and Pharmaceuticals Law, 2018-2025
- Chambers Europe, Band 1, Germany: Healthcare, 2024
- The Legal 500 EMEA, “Leading Individual” in Germany: Healthcare and Life Sciences, 2021-2024
- JUVE, recommended: Corporate, M&A, and Private Equity, and “Distinguished Advisor”: Health Services, 2022-2024
- Handelsblatt/Best Lawyers, “Lawyer of the Year” in Germany: Biotechnology Law and Life Sciences Practice, 2023
- Chambers Europe, “Leading Individual”, since 2011 continuously ranked Band 1 for Healthcare, 2023
- Who’s Who Legal, “Global Elite Thought Leader”: Healthcare, 2022
- Handelsblatt/Best Lawyers, “Leading Lawyer” in Germany: Mergers and Acquisitions Law and Pharmaceuticals Law, 2022
- Who’s Who Legal, Life Sciences and Healthcare, 2021
- Handelsblatt/Best Lawyers, “Lawyer of the Year” in Germany: Pharmaceuticals Law, 2021
- Expert Guides, “Best of the Best” in Germany: Regulatory, Finance & Transactional, 2018-2019
- Leaders League’s Guide, Innovation, Technology & Patents: “Excellent” in the Health, Pharma & Biotechnology category, 2019
- The Legal 500 EMEA, Recommended, Germany: Corporate M&A, 2017
- LMG Life Sciences: Life Science Star
- Member of the German-American Lawyers’ Association
- Member of German Association of Corporate Law
- Member of International Bar Association, Health, and Life Sciences Law Committee, Co-Chair
- Member of the advisory board of the Medical Law Institute (IMR) of the Bucerius Law School, Hamburg
Formazione
-
Dr. jur., Humboldt University Berlin, 2003
-
Second Legal State Exam, Berlin, 1998
-
First Legal State Exam, Heidelberg, 1996
-
University Paris-Dauphine, Maîtrise en économie appliquée, 1994
-
London School of Economics and Political Science, Master of Science in Government, 1993
- Germany
- Tedesco
- Inglese
- Francese
- Russo